Dividend King Growth Giant: J&J Faces Lilly Challenge
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
During recessions, some index funds fare better than others. This intro highlights selection criteria and defensive positioning.
25,743 articlesJohnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
A stylish post-wedding Italy escape hints at money-smart planning. Learn practical budgeting tips couples can borrow ...
Robinhood accelerates its blockchain push to compete with Coinbase, while Base narrows its focus to trading, payments...
Coinbase expands its crypto-backed loan service to include XRP and ADA, broadening access to liquidity without sellin...
Bitcoin faces a fresh test as five straight weeks of spot ETF withdrawals drain billions. Miners liquidate, bids thin...
Canaccord Genuity lowers AeroVironment's target to $330 but preserves a Buy rating, underscoring long-term optimism a...
A big stock move and a buyout rumor are reshaping how traders view NCR Atleos. A large block sale drew attention, jus...
Oil moved toward $110 a barrel after Iran signaled a broader escalation. The move adds risk to already tense energy m...
A leading AI investor says up to 80% of jobs could be AI-enabled by 2030, a view that’s fueling a new wave of policy ...
Ripple Prime gains a $200 million asset-based debt facility to push broader margin lending for institutions, signalin...
A new Milken-Harris poll shows 80% of Americans want government-backed AI workforce programs now, with 68% feeling th...
A breakthrough exploit on Arbitrum has exposed the hidden risk layers in defi’s automated yield protocols, shaking co...